Abstract:Objective:To investigate the effect of diabetes mellitus on the survival rate of liver transplant recipients with different grades of acute-on-chronic liver failure (ACLF) after liver transplantation.Methods:A retrospective study was carried out to investigate 1, 144 recipients with ACLF who underwent liver transplantation from January 1, 2017 to December 31, 2017 in the Scientific Registry of Transplant Recipients of American. According to whether they had diabetes before transplantation, the recipients were divided into two groups: non-diabetic group (n=927) and diabetic group (n=217). The survival rate was calculated by the Kaplan-Meier method and the survival curve was drawn, and then the log-rank test was used to compare the differences between two groups. The Cox proportional-hazards model was used to analyze the independent prognostic factors. A two-tailed P value <0.05 was considered statistically significant.Results:There were statistically significant differences in recipients′ age, body mass index (BMI), underlying liver disease, model for end-stage liver disease score, ACLF grade and postoperative hospital stay between diabetic and non-diabetic group (U/χ2=-6.290, -3.592, 76.451, -2.959, 8.150 and-2.542, all P <0.05). In terms of the donor characteristics, there was significant statistical difference in ABO blood type between the two groups (χ2=8.463, P<0.05). The proportion of recipients died from multiple organ failure after liver transplantation in the non-diabetic group (1.54%) was significantly lower than that in the diabetic group (5.16%) (χ2=8.863, P<0.05). There were no significant differences in terms of graft failure, cardio-cerebrovascular disease, hemorrhage, infection, malignant tumor and other diseases between the two groups (all P>0.05). The 1-, 2- and 3-year survival rates of ACLF1 recipients in the non-diabetic group were 93.1%, 90.5% and 88.7% by September 1, 2021, while those in the diabetic group were 93.8%, 92.2% and 92.2%, which had no statistically significance (χ2=1.021, P>0.05). The corresponding survival rates of ACLF2 recipients in non-diabetic group were 93.6%, 89.8% and 88.4% respectively, while those in diabetic group were 96.8%, 95.7% and 90.3%, which had no statistically significance (χ2=0.850, P>0.05). The corresponding survival rates of ACLF3 recipients in non-diabetic group were 91.5%, 89.2% and 87.5%, significantly better than those in diabetic group, which were 80.0%, 71.7% and 71.7% respectively (χ2=11.444, P<0.05). Multivariate analysis showed that recipient diabetes, ethnicity (African) and BMI were independent predictors of survival after liver transplantation in ACLF3 recipients (HR=2.31, 2.13 and 1.04, all P<0.05).Conclusions:Diabetes can significantly reduce the survival rates of ACLF3 recipients after liver transplantation, but it has no significant effect on ACLF1 and ACLF2 recipients. It is important to assess the diabetes status in ACLF3 recipients in the recipient selection process, in order to achieve better post-transplant survival.

Impact of New-Onset Diabetes after Transplantation on Cardiovascular Risk and Mortality in Korea: A Nationwide Population-Based Study

Influence of Dialysis Duration on Outcomes of Simultaneous Pancreas-Kidney Transplant

The effect of diabetes mellitus on the post-transplant survival rate of liver transplant recipients with different grades of acute-on-chronic liver failure

Influence of duration of type 1 diabetes on long-term pancreatic transplant outcomes.

New-Onset Diabetes after Liver Transplantation and Its Impact on Complications and Patient Survival

Influencing Factors of New-Onset Diabetes after a Renal Transplant and Their Effects on Complications and Survival Rate

The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study

New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry.

Association Between Preoperative Lipid Profiles and New-onset Diabetes after Transplantation in Chinese Kidney Transplant Recipients: a Retrospective Cohort Study

Incidence of new-onset diabetes and posttransplant metabolic syndrome after liver transplantation - A prospective Study From South India

New-Onset Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C: Analysis of the National Database.

Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes

Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and co-infection on the development of new-onset diabetes after kidney transplantation

Neutrophil: Lymphocyte and platelet: Lymphocyte ratios measured before transplantation and their correlation with new-onset diabetes post-transplantation in renal transplant recipients

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

The interaction of T2DM and BMI with NASH in recipients of liver transplants: an SRTR database analysis

Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis

New-onset Diabetes Mellitus Following Successful Kidney Transplantation Facilitates Aortic Stiffening

Association Between ADIPOQ Gene Polymorphisms and the Risk of New-Onset Diabetes Mellitus after Liver Transplantation

Glucagon-like Peptide 1 Receptor Agonists and Cardiovascular Outcomes in Solid Organ Transplant Recipients With Diabetes Mellitus

Risk factors and prediction score for new‐onset diabetes mellitus after liver transplantation